Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States)

被引:94
|
作者
Ngo, TH
Barnard, RJ
Tymchuk, CN
Cohen, P
Aronson, WJ
机构
[1] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA
关键词
apoptosis; dietary fat; IGF-I axis; physical activity; prostate cancer;
D O I
10.1023/A:1021911517010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Accumulating evidence indicates that prostate cancer is associated with high levels of serum IGF-I. This study was conducted to determine whether a low-fat diet and exercise (DE) intervention may modulate the IGF axis and reduce prostate cancer cell growth in vitro. Methods: Fasting serum was obtained from 14 men (age 60 +/- 3 years) participating in an 11-day DE program and from eight similarly aged men who had followed the DE program for 14.2 +/- 1.7 years (long-term). Insulin, IGF-I, IGFBP-1, and IGFBP-3 were measured by ELISA, and serum was used to stimulate LNCaP cell growth in vitro. Results: Serum IGF-I levels decreased by 20% while IGFBP-1 increased by 53% after 11-day DE. In the long-term group, IGF-I was 55% lower, while IGFBP-1 was 150% higher relative to baseline. Serum insulin decreased by 25% after 11-day DE and was 68% lower in the long-term group, relative to baseline. No changes in serum IGFBP-3 were observed. Serum-stimulated LNCaP cell growth was reduced by 30% in post-11-day serum and by 44% in long-term serum relative to baseline. LNCaP cells incubated with post-DE serum showed increased apoptosis/necrosis, compared to baseline. Conclusions: A low-fat diet and exercise intervention induces in-vivo changes in the circulating IGF axis and is associated with reduced growth and enhanced apoptosis/necrosis of LNCaP tumor cells in vitro.
引用
收藏
页码:929 / 935
页数:7
相关论文
共 50 条
  • [41] Ability of oocytes to fertilize with regard to insulin-like growth factor I (IGF-I) and IGF-binding proteins (IGFBP-1 and -3) levels in unstimulated IVF-ET cycles
    MedenVrtovec, H
    Tomazevic, T
    Osredkar, J
    Verdenik, I
    IN VITRO FERTILIZATION AND ASSISTED REPRODUCTION, 1997, : 333 - 337
  • [42] Association of plasma total IGF-I, IGFBP-1 and IGFBP-3 levels with incident coronary heart disease and ischemic stroke
    Kaplan, Robert C.
    McGinn, Aileen P.
    Pollak, Michael
    Kuller, Lewis
    Strickler, Howard D.
    Rohan, Tom
    Cappola, Anne R.
    Xue, XiaoNan
    Psaty, Bruce M.
    CIRCULATION, 2006, 114 (18) : 878 - 878
  • [43] THE CONCENTRATIONS OF INSULIN-LIKE GROWTH FACTOR-I (IGF-I) AND INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 (IGFBP-1) IN HUMAN MATERNAL AND UMBILICAL-CORD SERUM
    WANG, HS
    LIM, J
    ENGLISH, J
    IRVINE, L
    CHARD, T
    JOURNAL OF PHYSIOLOGY-LONDON, 1991, 438 : P235 - P235
  • [44] Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy:: relation to lipoprotein(a) levels
    Paassilta, M
    Karjalainen, A
    Kervinen, K
    Savolainen, MJ
    Heikkinen, J
    Bäckström, AC
    Kesäniemi, YA
    ATHEROSCLEROSIS, 2000, 149 (01) : 157 - 162
  • [45] Effect of dexamethasone treatment on serum GH, IGF-I, and the binding proteins IGFBP-1 and-3 in ventilated very preterm infants
    Huysman, MWA
    Hokken-Koelega, ACS
    Hop, WCJ
    Sauer, PJJ
    PEDIATRIC RESEARCH, 2003, 54 (01) : 37 - 43
  • [46] IGF-I, IGFV binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1, and postnatal growth in very low birth weight infants
    Kajantie, E
    Dunkel, L
    Rutanen, EM
    Seppälä, M
    Koistinen, R
    Sarnesto, A
    Andersson, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05): : 2171 - 2179
  • [47] RESPONSE OF INSULIN-LIKE GROWTH-FACTOR (IGF)-BINDING PROTEIN-1 (IGFBP-1) AND ICFBP-3 TO IGF-I TREATMENT IN SEVERE INSULIN-RESISTANCE
    QUIN, JD
    CHECKLEY, A
    GALLAGHER, A
    JONES, J
    MACCUISH, AC
    MIELL, JP
    JOURNAL OF ENDOCRINOLOGY, 1994, 141 (01) : 177 - 182
  • [48] Different inhibitory actions of IGFBP-1, -2 and -4 on IGF-I effects in vascular smooth muscle cells
    Gustafsson, T
    Andersson, P
    Arnqvist, HJ
    JOURNAL OF ENDOCRINOLOGY, 1999, 161 (02) : 245 - 253
  • [49] Maternal serum IGF-I, IGFBP-1 and IGFBP-3 at 11-13 weeks in trisomy 21 and trisomy 18 pregnancies
    Sifakis, Stavros
    Akolekar, Ranjit
    Kappou, Dimitra
    Mantas, Nikitas
    Nicolaides, Kypros H.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 157 (02) : 166 - 168
  • [50] The role of insulin growth factors binding proteins (IGFBP-1,-2,-3,-4,-6 and-7) and insulin growth factors (IGF-I and -II) in pediatric HSCT
    Pietrys, Danuta
    Tomasik, Przemyslaw J.
    Kwiecinska, Kinga
    Strojny, Wojciech
    Korostynski, Michal
    Piechota, Marcin
    Herbut, Katarzyna
    Balwierz, Walentyna
    Skoczen, Szymon
    BONE MARROW TRANSPLANTATION, 2018, 53 : 729 - 729